Tobacco smoking induces expression of very-high-affinity nicotine binding sites on blood polymorphonuclear cells

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 3, 1996, Pages 1056-1063

  Lebargy, François ^a   Benhammou, Khalid ^b   Morin, Didier ^b   Zini, Roland ^b   Urien, Saïk ^b   Brée, Françoise ^b   Bignon, Jean ^b   Branellec, Anne ^b   Lagrue, Gilbert ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SMOKING; SMOKING CESSATION;

EID: 0029881305     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.3.8630545     Document Type: Article

References (47)

1. U.S. Department of Health and Human Services, Public Health Service. 1988. The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General. U.S. Government Printing Office, Washington, DC. DHHS Publication No. (CDC) 88-8406.
2. Clarke, P. B. S., C. B. Pert, and A. Pert. 1984. Autoradiographic distribution of nicotine receptors in rat brain. Brain Res. 323:390-395.
3. Clarke, P. B. S., and A. Pert. 1985. Autoradiographic evidence for nicotine receptors on nigrostrial and mesolimbic dopaminergic neurons. Brain Res. 348:355-358.
4. 125I)-α bungarotoxin. J. Neurosci. 5:1307-1315.
5. Swanson, L. W., D. M. Simmons, P. J. Whitting, and J. Lindstrom. 1987. Immuno-histo-chemical localization of neuronal nicotinic receptors in the rodent central nervous system. J. Neurosci. 7:3334-3342.
6. Clouet, D., K. Asghar, and R. Brown. 1988. Mechanisms of cocaine abuse and toxicity. NIDA Research Monograph No. 88. National Institute of Drug Abuse.
7. Koob, G. F., and F. E. Bloom. 1988. Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
8. Imperato, A., A. Mulas, and G. Di Chiara. 1986. Nicotine preferentially stimulates dopamine release in the limbic system on freely moving rats. Eur. J. Pharmacol. 132:337-338.
9. 3H) dopamine release by nicotine in rat nucleus accumbens. J. Neurochem. 49:1449-1454.
10. Schwartz, R. D., and K. J. Kellar. 1983. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214-216.
11. Benwell, M. E., D. J. K. Balfour, and J. M. Anderson. 1988. Evidence that tobacco smoking increases the density of (-)-(3H) Nicotine binding sites in human brain. J. Neurochem. 50:1243-1247.
12. Richman, D. P., and B. G. W. Arnason. 1979. Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 76:4632-4635.
13. Davies, B. D., W. Hoss, J. P. Lin, and F. Lionetti. 1982. Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes. Mol. Cell. Biochem. 44:23-31.
14. Hoss, W., J. P. Lin, S. Matcett, and B. D. Davies. 1986. Characterization of noncholinergic nicotine receptors on human granulocytes. Biochem. Pharmacol. 14:2367-2372.
15. Maneckjee, R., and J. D. Minna. 1990. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. 87:3294-3298.
16. Chini, B., F. Clementi, N. Hukovic, and E. Sher. 1992. Neuronal-type α-bungarotoxin receptors and the α5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. Proc. Natl. Acad. Sci. U.S.A. 89:1572-1576.
17. Fagerstrom, K. O. 1978. Measuring degree of physical dependence to tobacco with reference to individualization of treatment. Addict. Behav. 3:235-241.
18. Peach, H., R. W. Morris, G. A. Ellard, and P. J. Jenner. 1985. A simple inexpensive urine test of smoking. Thorax 40:351-357.
19. Benowitz, N. L. 1988. Pharmacologic aspects of cigarette smoking and nicotine addiction. N. Engl. J. Med. 319:1318-1330.
20. Aguado, M. T., N. Pujol, E. Rubiol, M. Tura, and A. Celada. 1980. Separation of granulocytes from peripheral blood in a single step using discontinuous density gradients of Ficoll-Urographin. A comparative study with separation by Dextran. J. Immunol. Methods 32:41-50.
21. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
22. Romano, C., and A. Goldstein. 1980. Stereospecific nicotine receptors on rat brain membranes. Science 310:647-649.
23. Marks, M. J., and A. C. Collins. 1982. Characterization of nicotine binding in mouse brain and comparison with the binding of a bungarotoxin and quinuclidinyl benzylate. Mol. Pharmacol. 22:554-564.
24. 3H)nicotine eliminates low affinity binding. Life Sci. 46:935-943.
25. Gies, J. P., B. Ilien, and Y. Landry. 1987. Temperature-dependence and heterogeneity of muscarinic agonist and antagonist binding. Biochem. Pharmacol. 36:2589-2597.
26. Madsen, B. W., and J. S. Robertson. 1974. Improved parameters estimates in drug-protein binding studies by nonlinear regression. J. Pharmacol. 26:807-813.
27. Urien, S. 1991. Micropharm, a software designed to analyse pharmacological data from kinetic binding and tissue extraction experiments. Bull. Cancer (Paris) 78:654.
28. 3H) (-) nicotine to rat brain membranes. FEBS Lett. 157: 147-149.
29. 3H) (-) nicotine. J. Neurochem. 43:604-610.
30. 3H) (-) nicotine binding sites in fetal human brain. Brain Res. 475:1-7.
31. Wonnacott, S. 1987. Brain nicotine binding sites. Hum. Toxicol. 6: 343-353.
32. Asher, P., W. A. Large, and H. P. Rang. 1979. Studies on the mechanism of action of acetylcholine antagonists on rat parasympathic ganglion cells. J. Physiol. (London) 295:139-170.
33. Large, W. A., and J. A. Sim. 1986. A comparison between mechanisms of action of different nicotinic blocking agents on rat submandibular ganglia. Br. J. Pharmacol. 89:583-592.
34. Marks, M. J., J. B. Burch, and A. C. Collins. 1983. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226:817-825.
35. 3H) acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J. Neurochem. 45:427-433.
36. Rapier, C., G. G. Lunt, and S. Wonnacott. 1988. Stereoselective nicotine induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem. 50:1123-1130.
37. Huilhan-Giblin, B. A., M. D. Lumkin, and K. J. Kellar. 1989. Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. J. Pharmacol. Exp. Ther. 252:21-25.
38. Sugiyama, H., and J. P. Changeux. 1975. Interconversion between different states of affinity for acetylcholine of the cholinergic receptor protein from Torpedo marmorata. Eur. J. Biochem. 55:505-515.
39. Weber, M., T. David-Pfeuty, and J. P. Changeux. 1975. Regulation of binding properties of nicotinic receptor protein by cholinergic ligands in membrane fragment from Torpedo marmorata. Proc. Natl. Acad. Sci. U.S.A. 72:3443-3447.
40. Weiland, G., and P. Taylor. 1978. Ligand specificity of state transitions in the cholinergic receptor: behavior of agonists and antagonists. Mol. Pharmacol. 15:197-212.
41. Lindstrom, J., R. Schoepfer, W. G. Conroy, and P. Whiting. 1990. Structural and Functional Heterogeneity of Nicotinic Receptors. Ciba Foundation Symposium 152. The Biology of Nicotine Dependence. Wiley-Interscience, New York. 23-52.
42. Luetje, C. W., J. Patrick, and P. Seguela. 1990. Nicotine receptors in the mammalian brain. FASEB J. 4:2753-2760.
43. Deneris, E. S., J. Connolly, S. W. Rogers, and R. Duvoisin. 1991. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 12:34-40.
44. Kurosaki, T., K. Fukuda, T. Konno, Y. Mori, K. I. Takana, M. Mishina, and S. Numa. 1987. Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations. FEBS Lett. 214:253-258.
45. Leutje, C. W., and J. Patrick. 1991. Both α-and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. Neuroscience 11:837-845.
46. Connolly, J., J. Boulter, and S. F. Heinemann. 1992. α4-β2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmacol. 105:657-666.
47. Silagy, C., D. Mant, G. Fowler, and M. Lodge. 1994. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343:139-142.